Altimmune (ALT) Change in Taxes (2016 - 2021)
Altimmune (ALT) reported Change in Taxes of $2.6 million for Q3 2021, up 276.83% year-over-year from $686908.0 in Q3 2020, and up 356.26% on a QoQ basis from -$1.0 million in Q2 2021.
Altimmune (ALT) has 6 years of Change in Taxes data on file, last reported at $2.6 million in Q3 2021.
- Quarterly Change in Taxes rose 276.83% year-over-year to $2.6 million in Q3 2021, while the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, changed N/A from the prior year.
- Change in Taxes advanced to $2.6 million in Q3 2021 per ALT's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Change in Taxes topped out at $3.4 million in Q1 2020 and bottomed at -$2.9 million in Q2 2018.
- The 5-year median for Change in Taxes is $203008.0 (2017), against an average of $357730.5.
- The widest annual swing landed in 2018, when Change in Taxes tumbled 662.91%; it then soared 10982.67% in 2020.
- Tracing ALT's Change in Taxes over 5 years: stood at $1.3 million in 2017, then plunged by 118.79% to -$237442.0 in 2018, then plunged by 42.98% to -$339501.0 in 2019, then soared by 562.13% to $1.6 million in 2020, then soared by 64.98% to $2.6 million in 2021.
- Per Business Quant, the three latest ALT Change in Taxes figures stand at $2.6 million (Q3 2021), -$1.0 million (Q2 2021), and $135274.0 (Q1 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2.59 Mn |
| Sep 30, 2021 | 2.59 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Mar 31, 2021 | 135,274.00 |
| Mar 31, 2021 | 135,274.00 |
| Dec 31, 2020 | 1.57 Mn |
| Dec 31, 2020 | 1.57 Mn |
| Sep 30, 2020 | 686,908.00 |
| Sep 30, 2020 | 686,908.00 |
| Jun 30, 2020 | 1.52 Mn |
| Jun 30, 2020 | 1.52 Mn |
| Mar 31, 2020 | 3.36 Mn |
| Mar 31, 2020 | 3.36 Mn |
| Dec 31, 2019 | -339,501.00 |
| Dec 31, 2019 | -339,501.00 |
| Sep 30, 2019 | -111,962.00 |
| Sep 30, 2019 | -111,962.00 |
| Jun 30, 2019 | 13,690.00 |
| Jun 30, 2019 | 13,690.00 |
| Mar 31, 2019 | 57,896.00 |
| Mar 31, 2019 | 57,896.00 |
| Dec 31, 2018 | -237,442.00 |
| Dec 31, 2018 | -237,442.00 |
| Sep 30, 2018 | -2.60 Mn |
| Sep 30, 2018 | -2.60 Mn |
| Jun 30, 2018 | -2.94 Mn |
| Jun 30, 2018 | -2.94 Mn |
| Mar 31, 2018 | 694,200.00 |
| Mar 31, 2018 | 694,200.00 |
| Dec 31, 2017 | 1.26 Mn |
| Dec 31, 2017 | 1.26 Mn |
| Sep 30, 2017 | 1.42 Mn |
| Sep 30, 2017 | 1.42 Mn |
| Jun 30, 2017 | 522,098.00 |
| Jun 30, 2017 | 522,098.00 |
| Mar 31, 2017 | 203,008.00 |
| Mar 31, 2017 | 203,008.00 |
| Dec 31, 2016 | -46,537.00 |
| Dec 31, 2016 | -46,537.00 |
| Sep 30, 2016 | 284,131.00 |
| Sep 30, 2016 | 284,131.00 |
| Jun 30, 2016 | 87,584.00 |
| Jun 30, 2016 | 87,584.00 |